//

C-Path’s Stephenson Appears on Xtalks’ Life Science Podcast to Talk Future of Drug Development in Parkinson’s, Alzheimer’s

Critical Path Institute’s Diane Stephenson, Ph.D., Vice President of Neurology, and Executive Director of its Critical Path for Parkinson’s Consortium recently appeared on the The Xtalks Life Science Podcast. Hosted by Ayesha Rashid and joined by Digital Medicine Society (DiME) Research Lead Sarah Averill Lott, MPH, CPH, this episode discusses the collaboration between DiME and C-Path in advancing research and care in neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases. Sarah and Diane make the case that digital health technologies can be vital in diagnosing and managing these complex diseases more effectively.

The conversation highlights how these organizations work together to create resources that allow for better utilization of digital measures in clinical trials, aiming for improved patient outcomes. Key discussion points included the barriers to adopting digital health tools, the importance of early intervention, and the potential for improved patient empowerment through technology. Both speakers emphasize the need for public-private partnerships and collaborative efforts across various stakeholders to overcome the challenges facing Alzheimer’s and Parkinson’s research.

You can watch the episode on Xtalks’ YouTube page below, or on the Xtalks blog here.

share
Facebook